L&P Convinces Federal Circuit to Revise Board’s Overbroad Claim Interpretation Press ReleaseKevin LaurenceNovember 6, 2017
L&P Co-Sponsors the 4th Annual Corporate IP Strategy Conference (CIPSC) Conferences/SeminarsKevin LaurenceOctober 19, 2017
Trial Instituted Against Novartis’s Patent for Afinitor® Drug Press ReleaseKevin LaurenceSeptember 29, 2017
Kevin Laurence Speaking on Post-Grant Review Options at Kraus & Weisert’s Seminar in Munich, Germany Conferences/SeminarsKevin LaurenceSeptember 19, 2017
L&P Attorneys Teach “Post-Grant Patent Practice” Advanced Course for PRG Conferences/SeminarsKevin LaurenceSeptember 15, 2017
L&P Co-Sponsors the 3rd Post-Grant Practice Roundtable Discussion at GWU Conferences/SeminarsKevin LaurenceSeptember 8, 2017
Kevin Laurence Participates in Panel at IPO’s Annual Meeting on Post-Grant Proceedings Conferences/SeminarsKevin LaurenceSeptember 1, 2017
L&P's Client Argentum Pharmaceuticals and Eli Lilly Settle Patent Dispute over Cialis® Drug Press ReleaseKevin LaurenceAugust 22, 2017
Kevin Laurence will present at the 254th American Chemical Society National Meeting in Washington, D.C. Conferences/SeminarsKevin LaurenceAugust 8, 2017
L&P Files IPR Petition for Unified Patents against Hailo's Patent Press ReleaseKevin LaurenceAugust 1, 2017
L&P Convinces the PTAB to Reverse Examiner’s Rejections of Client’s Claims Press ReleaseKevin LaurenceJuly 25, 2017
L&P's Ex Parte PTAB Appeal Victory Results in Reversal of Examiner’s Rejections Press ReleaseKevin LaurenceJuly 24, 2017
L&P Convinces the PTAB not to Institute Trial against Memory Chip Patent Press ReleaseKevin LaurenceJune 23, 2017
